SlideShare a Scribd company logo
Fluid Balance For Surgical Patients
1
Dr. Ahmed Sayed Khashaba, MBBS. MD. Ph.D.
Associate Professor of Medical Physiology
College of Applied Medical Sciences
Basic Sciences Department
Riyadh Elm University
Kingdom of Saudi Arabia, P.O. Box: 84891 Riyadh
11681
Tel: 0112481222, ext. 324
email: ahmedkhashaba@riyadh.edu.sa
Intended Learning Outcomes
• Describe the physiology of human fluid dynamics.
• Define Intravenous therapy.
• List the aims of adult perioperative fluid therapy.
• Recognize the commonly used fluid preparations.
• Describe the properties and indications of commonly used IV solutions.
• Describe the side effects and precautions of commonly used IV solutions.
• Explain the (NICE) principles and protocols for intravenous fluid therapy.
• Discuss the assessment and management of hydration and volume status of surgical patients.
• Describe the type, rate and volume of fluid administered to surgical patients.
• Recognize the different types of venous access.
• Explain the potential local complications of peripheral IV therapy.
• Identify the universal equations used by nurses to calculate the IV flow rate and medication dosage.
I. Physiology-Body Fluid Compartments
■Total body water (TBW) is approximately
60% of body weight.
■A. Distribution of water
1. Intracellular fluid (ICF)
■is two-thirds of TBW.
■The major cations of ICF are K+ and Mg2+.
■The major anions of ICF are protein and organic
phosphates.
2. Extracellular fluid (ECF)
■is one-third of TBW.
■is composed of interstitial fluid and
plasma. The major cation of ECF is
Na+.
■The major anions of ECF are Cl- and HCO3-.
a. Plasma is one-fourth of the ECF.
■The major plasma proteins are albumin and
globulins.
b. Interstitial fluid is three-fourths of the ECF.
■The composition of interstitial fluid is the same
as that of Plasma except that it has little protein.
Thus, interstitial fluid is an ultrafiltrate of plasma.
3. 60-40-20 rule
■TBW is 60% of body weight.
■ICF is 40% of body weight.
■ECF is 20% of body weight.
4- Normal Fluid Balance
N.B. Water requirements increase by 100 to 150 mL/day for each ○C of body temperature elevation.
5. Examples of shifts of water between compartments
a. Sweating in a desert—loss of water
■is also called hyperosmotic volume contraction.
(1)The osmolarity of ECF increases because sweat is hyposmotic
(relatively more water than salt is lost).
(2)ECF volume decreases because of the loss of volume in the sweat.
(3)Water shifts out of ICF; as a result of the shift, ICF osmolarity
increases until it is equal to ECF osmolarity, and ICF volume decreases.
b. Excessive NaCl intake—addition of NaCl
■is also called hyperosmotic volume expansion.
(1)The osmolarity of ECF increases because osmoles (NaCl) have been
added to the ECF.
(2)Water shifts from ICF to ECF. As a result of this shift, ICF osmolarity
increases until it equals that of ECF.
(3)As a result of the shift of water out of the cells, ECF volume
increases (volume expansion) and ICF volume decreases.
II- Distribution of Electrolytes
III. Concentration and dilution of urine
• Produced by
HYPOTHALAMUS.
• Stored by
POSTERIOR
PITUITARY
• Decrease amount of
water loss
• Vasoconstriction.
• Made by cells of Adrenal
cortex (Zona Glomerulosa)
• Controls levels of Na+
& K+ in ECF.
• Simultaneous
reabsorption of Na+ &
excretion of K+.
• Water follows Na+
• Atrialnatriureticpeptide(ANP)made
by cells of Right Atrium when
blood volume increases
(atria stretched).
• Brain natriuretic peptide (BNP)
produced from stretched
ventricles.
• Promote loss of water
& Na+,(-) Renin, (-)ADH
& Aldosterone
27
IV- Hormonal effects on fluid homeostasis
V- Starling's forces
• Represent the movement of fluids at the vascular
endothelium. Starling's forces describe the movement of
fluids at the vascular endothelium. Starling described 4
forces: (a) the capillary hydrostatic pressure, (b) the capillary
oncotic pressure, (c) the interstitial hydrostatic pressure, and
(d) the interstitial oncotic pressure. The sum of the four
forces results in the net movement of small amounts of fluid
across the vascular endothelium into the interstitial space.
Normally, the lymphatic system returns this fluid to the
circulation to prevent interstitial edema (Saraghi, M., 2015.
Intraoperative fluids and fluid management for ambulatory
dental sedation and general anesthesia).
• In patients who are septic, the tight junctions between the
capillary endothelial cells break down and vascular
permeability increases. As a result, increasing hydrostatic
pressures and reducing oncotic pressure lead to fluid leaving
the vasculature and entering the tissue. It is often therefore
necessary to give relatively large volumes of intravenous fluid
to maintain the intra-vascular volume. Close monitoring of
the fluid balance will be required.
Definition:
Intravenous therapy, also referred to as ‘IV therapy’, constitutes the
administration of liquid substances directly into a vein and the general circulation
through venepuncture (Mosby, 1998).
INTRAVENOUS THERAPY
11
AIMS OF IV FLUID THERAPY
The intravenous route is a fast and efficient method to administer fluids and medication,
which can be given continuously or intermittently.
Intravenous fluid therapy may be used to:
• Replace fluids and replace imbalances.
• Maintain fluid, electrolyte and acid-base balance.
• Administer blood and blood products.
• Administer medication.
• Provide parenteral nutrition.
• Monitor cardiac function.
IV Fluids can be broadly categorized into two groups:
1- Crystalloids: are more widely used than colloids, with research supporting the
idea that neither is superior in replenishing intravascular volume for
resuscitation purposes (with crystalloids also significantly cheaper). Therefore,
crystalloids are used very commonly in the acute setting, in theatres, and for
maintenance fluids.
2- Colloids: One advantage of colloids is that they remain in the intravascular
space for longer periods of time with less risk of peripheral and pulmonary
edema. Commonly used colloids include albumin, hydroxyethyl starch, and
dextran. Disadvantages include increased cost and risks for hypersensitivity
reactions, coagulopathy, and renal failure. Colloids expand the volume of the
intravascular space, resulting in dilution of blood cells, platelets, and coagulation
can inhibit coagulation. Dextran, in particular, affect coagulation. Serious allergic
or anaphylactoid reactions are another disadvantage associated with colloid
administration. The crystalloid versus colloid debate continues and is one of the
unresolved questions in perioperative fluid management.
Compositions of Commonly Prescribed Crystalloids
Properties and Indications of Commonly Used IV Fluids
Different types of crystalloids have different properties and will, therefore, be appropriate in
different situations according to the cause of fluid loss and the patient’s condition.
1- Isotonic crystalloids have a sodium and a chloride concentration of 154mmol/L and a similar
electrolyte concentration to plasma. With isotonic infusions, there is no significant fluid shift
across cellular or vascular membrane for a normally hydrated patient. These fluids are usually
used to treat low extracellular fluid loss (for example, in a dehydrated patient), in fluid challenge
or during fluid resuscitation.
2- Balanced crystalloid solutions (e.g., lactated Ringer’s). They are called ‘balanced’ because
their ionic composition is closer to the human body’s plasma levels than other crystalloids. A
post-operative patient at risk of fluid loss leading to electrolyte imbalance, for example, will
benefit from balanced crystalloids.
3- Hypotonic crystalloids have a lower osmolarity than plasma, which means they cause fluids
to shift from the intravascular space to the intracellular or interstitial space. They also help the
kidneys excrete fluids and electrolytes, and are often used in patients with diabetic
ketoacidosis.
4- Hypertonic crystalloids have a higher electrolyte concentration than plasma and, therefore,
draw fluid from the intracellular and interstitial space into the intravascular space. They may be
used to treat patients with cerebral oedema.
IV FLUID CHOICE FOR DENTAL, ORAL, AND MAXILLOFACIAL PROCEDURES
• For outpatient treatments involving sedation/general anesthesia and just modest blood loss,
such as most dentistry and oral surgery, isotonic balanced crystalloids are the preferred fluid.
• The majority of patients who come in for surgery have not just an intravascular fluid deficit
but also an interstitial space deficit. Thankfully, crystalloid will compensate for the losses in
both compartments. Insensible and urine losses are minimal in most office-based dental and
oral surgery procedures.
• Colloids have no place in office-based dental and minor oral treatments, and their use is
limited to prolonged and/or invasive maxillofacial surgical operations involving significant
blood loss and advanced monitoring of blood pressure and/or urinary output (Saraghi, M.,
2015. Intraoperative fluids and fluid management for ambulatory dental sedation and general
anesthesia).
Side-effects and Precautions of Commonly Used IV Fluids
1- Isotonic crystalloids should be used with caution in patients with cardiac or renal disease,
as there is a risk of fluid overload. Patients’ sodium and chloride levels need to be monitored
regularly to avoid hypernatraemia and hyperchloraemia. All isotonic crystalloids can cause
peripheral and pulmonary oedema.
2- The lactate contained in balanced isotonics is metabolized by the liver into bicarbonate, so
these fluids should not be used in patients who cannot metabolize lactate due to liver
disease; nor should they be administered to patients with pH >7.5. They should be used with
caution in patients with renal failure because of the kidneys’ inability to filter potassium.
3- Hypotonic crystalloids should not be administered to patients at risk of increased
intracranial pressure, those with liver disease or trauma or burns patients, mainly because
these patients need to maintain a good intravascular volume.
4- Hypertonic crystalloids main risks are hypernatraemia and hyperchloraemia, so these fluids
need to be given slowly and cautiously to avoid intravascular fluid overload and pulmonary
oedema. It is also worth noting that 20% dextrose is an osmotic diuretic. Hypertonic solutions
should not be given to patients with cardiac conditions, as there is a risk of fluid overload.
IV Fluid Replacement Precautions in Specific Patients
• Patients with hypernatremia who receive fluid replacement with quick correction of
hypernatremia are more likely to develop cerebral edema due to increased intracellular and
extracellular fluid loads, as well as increased pressure inside the brain region. This results in
neurological damage and, eventually, death. This situation can be averted by slowly infusing
fluids to lower sodium levels at a rate of 2 to 3 mEq/L per hour for a total change of 12
mEq/L per day until sodium levels return to normal.
• Rapid correction of hyponatremic patients, on the other hand, may result in central pontine
myelinolysis syndrome. When hyponatremia is quickly treated, brain cells shrink and the
blood-brain barrier's tight connections are broken, resulting in cell injury and neuron
demyelination. This can result in a condition known as "locked-in syndrome’’ which is
characterized by paralysis, dysphagia, and dysarthria. The serum sodium should be increased
by approximately 1 to 2 mEq/L per hour until the neurologic symptoms of hyponatremia
subside or until plasma sodium concentration is over 120 mEq/L.
• Diabetic ketoacidosis is a diabetic condition that occurs when the body is unable to use
glucose for energy production. Glucose is an osmotically active molecule excreted at high
amounts in the urine (osmotic diuresis). Dehydration arises as a result of the excessive fluid
loss through urine. This demands a large volume resuscitation of approximately 6 to 9 liters
of normal saline (Brinkman, J.E., Dorius, B. and Sharma, S., 2018. Physiology, Body Fluids).
National Institute for Health and Care Excellence (NICE) Principles and
protocols for intravenous fluid therapy
• The assessment and management of patients’ fluid and electrolyte needs are fundamental to
good patient care. Fluid balance is an important area of perioperative medicine. If managed
incorrectly it is a significant cause of morbidity.
• Provide intravenous (IV) fluid therapy only for patients whose needs cannot be met by oral or
enteral routes, and stop as soon as possible.
• When prescribing IV fluids, remember the five Rs after the initial assessment:
resuscitation, routine maintenance, replacement, redistribution, and reassessment.
•  Offer IV fluid therapy as part of the following protocol:
– Assess patients’ fluid and electrolyte needs following algorithm 1 (assessment)
– If patients need IV fluids for resuscitation, follow algorithm 2 (fluid resuscitation)
– If patients need IV fluids for routine maintenance, follow algorithm 3 (routine maintenance)
– If patients need IV fluids to address existing deficits or excesses, ongoing abnormal losses, or
abnormal fluid distribution, follow algorithm 4 (replacement and redistribution).
• Include the following information in IV fluid prescriptions:
– The type of fluid to be administered
– The rate and volume of fluid to be administered.
– The fluid and electrolyte prescription over the next 24 hours.
I- Assessment of Fluid Status
• It is essential to utilize various clinical parameters to continually assess the patient’s
fluid status. A doctor’s first assessment is the patient’s clinical status.
• Assess the patient using the ABCDE approach (airway, breathing, circulation, disability,
exposure).
A- In the fluid depleted patients (HYPOVOLEMIA), one should be looking for:
• Dry mucous membranes and reduced skin turgor
• Decreasing urine output (should target >0.5 ml/kg/hr)
• Orthostatic hypotension
• In worsening stages:
• Systolic blood pressure <100mmHg;
• Heart rate >90 beats per minute;
• Capillary refill time >2 seconds or peripheries cold to touch;
• Respiratory rate >20 breaths per minute;
• NEWS ≥ 5.
• Passive leg raising suggesting fluid responsiveness.
B- In patients who may be fluid overloaded (HYPERVOLEMIA), one should be looking for:
• Raised Jugular Venous Pressure (JVP)
• Peripheral or sacral oedema
• Pulmonary oedema
C- Ensure that the patient has a fluid input-output chart and daily weight chart commenced
via nursing staff. Also ensure to monitor the patient’s urea and electrolytes (U&Es) regularly,
for any evidence of dehydration, renal hypoperfusion, or electrolyte abnormalities.
N.B. NEWS should be used as an aid to clinical assessment, and is not a substitute for sound clinical judgement. Therefore
a low score is not necessarily reassuring but the higher the NEWS, the greater the clinical risk.
A *RED score refers to an extreme variation in a single physiological parameter and warrants clinical evaluation.
N.B. Hypervolemia can be managed by fluid restriction, diuretics, and dialysis in severe cases.
II. RESUSCITATION
Resuscitation is correction of existing abnormalities in volume status or serum
electrolytes (as in hypovolemic shock).
• Regardless of the etiology of volume depletion, the mainstay of treatment
strategy is a goal-directed resuscitation to restore intravascular volume. This will
contribute to improved cardiovascular function and tissue perfusion.
• As the extracellular space is restored, focus can begin to shift towards
maintaining the current extracellular volume state and restoring intracellular
volume. Electrolyte correction can occur during and after the maintenance
phase is established.
• Correction may be anticipated from the clinical context and verified using
diagnostic tests.
• With adequate tissue perfusion, most pH abnormalities should correct.
• The inverted pyramid below illustrates the focus of acute management in
descending order of priority:
II- RESUSCITATION (Continued)
• Any reduced urine output (<0.5ml/kg/hr.) should be managed aggressively, the fluid
challenge should be urgently administered according to the clinical parameters, including
the urine output.
• The fluid challenge should be either 250ml or 500ml over 15-30mins, depending on the
patient’s size and co-morbidities.
• Fluids can be given in a variety of ways. A large observational research revealed significant
differences in practice. Crystalloids made up 74.3 percent of the fluids utilized in the
challenge, with 0.9 percent saline accounting for 45.9 percent and 53.5 percent balanced
solutions, with colloids accounting for the remaining 25.6 percent (Cecconi, Maurizio, et al.
2015. Fluid challenges in intensive care: the FENICE study).
• Ongoing Monitoring of Fluid Challenge
Frank Starlings Law and SV maximization:
• The relationship between preload and stroke volume is best described by the Frank-Starling
curve. An increased venous return, or increased preload increases ventricular filling and the
end-diastolic volume. This increases the stretch of the cardiac myocyte, which increases
sarcomere length with the resultant increased force of contraction, leading to an increase in
the volume of blood ejected from the heart. For a fluid challenge to be effective, it, therefore,
needs to be of sufficient volume to cause stretch of the cardiac myocytes and test the Frank-
Starling principle. If the heart can accommodate the increased volume, then stroke volume
will increase; otherwise, the volume will remain within the venous system (Bennett, V.A. and
Cecconi, M., 2017. Perioperative fluid management: From physiology to improving clinical
outcomes).
Frank Starlings Law and SV maximization
N.B. When giving the fluid challenge, the following are the signs of fluid responsiveness:
• ≥ 10–15% increase in cardiac output (CO) or stroke volume (SV)
• Increase in systolic blood pressure
• Normalization of heart rate and respiratory rate
• Increase in urine output ≥ 0.5 mL/kg/hour
A number of minimally invasive and noninvasive diagnostic tools are currently available that
allow clinicians to assess volume responsiveness using dynamic procedures that challenge the
patients' Frank-Starling curve. These technologies complement one another; each has a useful
place in the continuum of the resuscitation process.
N.B.
Esophageal Doppler monitoring (EDM) was recently endorsed by the National Health Service as a rational
alternative to central venous pressure monitoring in patients undergoing major surgery.
III- Routine Maintenance (Daily Requirements)
• Providing the patient’s renal function is adequate
and is Clinically Euvolemic, maintenance therapy is
usually undertaken when the individual is not
expected to eat or drink normally for a longer time
(e.g., perioperatively or patient on a ventilator).
• Patients do not just require water, they also need
Na+, K+, and glucose replacing too, particularly if
they are nil by mouth (NPO). There are numerous
ways of calculating the daily requirements of the
following four components and they are invariably
based on the patient’s weight.
• Current National Institute for Health and Care
Excellence (NICE) guidelines suggest the following:
• 1- Water: 25 mL/kg/day
• 2- Na+: 1.0 mmol/kg/day
• 3- K+: 1.0 mmol/kg/day
• 4- Glucose: 50g/day
Based on these required, it is necessary to consider
the fluids that are available for prescription and what
exactly they contain, to be able to prescribe
appropriately.
A Practical Example on Routine Maintenance:
- Let us say that our patient is a 70kg healthy male.
• From the daily requirements mentioned in the previous slide, we need to prescribe fluids
over 24 hours that provide 1750mL of water (70kg x 25mL/kg/day), 70mmol of Na+ (70kg x
1.0mmol/kg/day), 70mmol of K+ (70kg x 1.0mmol/kg/day), and 50g (50g/day) of glucose.
• Consequently, a typical fluid maintenance regimen is as follows:
• First bag: 500mL of 0.9% saline with 20mmol/L K+ to be run over 8 hours
• This provides all of their Na+, ~1/3rd of their K+, and a quarter of their water.
• Second bag: 1L of 5% dextrose with 20mmol/L K+ to run over 8 hours
• This provides a further 1/3rd of their K+, and half of their water, as well as glucose.
• Third bag: 500mL of 5% dextrose with 20mmol/L K+ to run over 8 hours
• This provides the remaining 1/3rd of their K+, and a quarter of their water, as well as
glucose.
IV- Replacement and Redistribution
Aspects to be replaced may include:
• Are there any third-space losses?
• Third-space losses refer to fluid losses into spaces that are not visible,
such as the bowel lumen (in bowel obstruction) or the retroperitoneum (as
in pancreatitis).
• Is the patient losing electrolyte-rich fluid?
Common scenarios of electrolyte imbalances through fluid losses that
may be encountered include dehydration (high urea: creatinine ratio
and high PCV), vomiting (low K+, low Cl–, and alkalosis), or diarrhea
(low K+ and acidosis).
A. Dehydration
Dehydration is largely due to inadequate water intake to meet the body’s metabolic needs. The average
adult has an obligatory intake requirement of 1500 mL per day. This value increases depending on activity
and metabolism. Primary sources of normal fluid loss include urine, sweat, respiration, and stool.
• Dehydration manifests clinically as decreased urine output, dizziness, fatigue, tachycardia, increased skin
turgidity, and fatigue or confusion in severe cases.
• Whenever possible, oral fluid replacement should be attempted. In more urgent situations, IV fluid
replenishment should be based on bolus supplementation of the deficit of fluids and a maintenance
replenishment of obligatory intake requirements.
The fluid deficit can be calculated when the pre-dehydration weight and post-dehydration weight are
known.
• The equation in males is:
Deficit = 0.6 X weight in kilograms X [1-(140/measured Na+)]
• The equation in females is:
Deficit = 0.5 X weight in kilograms X [1-(140/measured Na+)]
• IV fluid replacement options include normal saline (0.9% NaCl), one-half normal saline (0.45% NaCl),
Dextrose 5% in either normal saline or one-half normal saline, and lactated Ringer's solution.
• The choice of replacement fluids is patient scenario-specific and dependent on the electrolyte status of
laboratory evaluation.
B. Vomiting
A man is admitted to the hospital for evaluation of severe
epigastric pain. He has had persistent nausea and vomiting
for 4 days. Upper gastrointestinal (GI) endoscopy shows a
pyloric ulcer with partial gastric outlet obstruction. He has
orthostatic hypotension, decreased serum [K+], decreased
serum [Cl−], arterial blood gases consistent with
metabolic alkalosis, and decreased ventilation rate.
a. Loss of H+ from the stomach by vomiting causes
increased blood [HCO3-] and metabolic alkalosis. Because
Cl− is lost from the stomach along with H+,
hypochloremia and ECF volume contraction occur.
b. The decreased ventilation rate is the respiratory
compensation for metabolic alkalosis.
c. ECF volume contraction is associated with production of
angiotensin II is increased. Thus, the ECF volume
contraction worsens the metabolic alkalosis because
angiotensin II increases HCO3− reabsorption in the
proximal tubule (contraction alkalosis).
d. The increased levels of aldosterone causes increased
distal H+ secretion, further worsening the metabolic
alkalosis.
e. The choice of the IV fluid replacement fluid is
dependent on the electrolyte status of laboratory evaluation
to correct ECF volume contraction.
C. Diarrhea
A man returns from a trip abroad with “traveler’s diarrhea.” He has weakness, weight loss, orthostatic
hypotension, increased pulse rate, increased breathing rate, pale skin, a serum [Na+] of 132 mEq/L, a serum
[Cl−] of 111 mEq/L, and a serum [K+] of 2.3 mEq/L. His arterial blood gases are pH, 7.25; Pco2, 24 mm Hg;
HCO3-, 10.2 mEq/L.
a. Loss of HCO3- from the GI tract causes a decrease in the blood [HCO3−] and, according to the
Henderson-Hasselbalch equation, a decrease in blood pH. Thus, this man has metabolic acidosis.
b. The increased breathing rate (hyperventilation) is the respiratory compensation for metabolic acidosis.
c. As a result of his diarrhea, this man has ECF volume contraction, which leads to decreases in blood
volume and arterial pressure. The decrease in arterial pressure activates the baroreceptor reflex, resulting
in increased sympathetic outflow to the heart and blood vessels. The increased pulse rate is a consequence
of increased sympathetic activity in the sinoatrial (SA) node, and the pale skin is the result of cutaneous
vasoconstriction.
d. ECF volume contraction also activates the renin–angiotensin–aldosterone system. Increased levels of
aldosterone lead to increased distal K+ secretion and hypokalemia. Loss of K+ in diarrhea fluid also
contributes to hypokalemia.
e. Treatment consists of replacing all fluid and electrolytes lost in diarrhea fluid and urine, including Na+,
HCO3−, and K+ by administrating isotonic balanced IV fluid.
e- If more Potassium IV infusion is indicated, it should not be administered exceeding 10 mmol/hour, and
maximum dose in 24 hours should not exceed 200 mmol.
V. Reassessment
• If the patient is receiving IV fluids for resuscitation, reassess the patient using the ABCDE;
monitor respiratory rate, pulse, blood pressure, and perfusion continuously; and measure
venous lactate level or arterial pH and base excess according to the Resuscitation Council’s
guidance on advanced life support.
• All patients continuing to receive IV fluids need regular monitoring. This should initially
include at least daily reassessments of clinical fluid status, laboratory values (urea, creatinine,
and electrolytes), and fluid balance charts, along with weight measurement twice weekly.
• Additional monitoring of urinary sodium may be helpful in patients with high volume
gastrointestinal losses: reduced urinary sodium excretion (<30 mmol/L) may indicate total
body sodium depletion even if plasma sodium levels are normal; however, urinary sodium
values may be misleading in the presence of renal impairment or diuretic therapy.
• If patients have received IV fluids containing chloride concentrations >120 mmol/L (such as
saline 0.9%), monitor their serum chloride concentration daily. If patients develop
hyperchloraemic acidosis, reassess their IV fluid prescription and assess their acid-base
status. Using balanced electrolyte solutions that contain base or base-equivalents and
chloride concentrations that are more physiologic may not only prevent the development of
hyperchloremic acidosis, but may avoid some of the possible harmful effects of associated
with hyperchloremic solutions such as normal saline.
Hourly maintenance is determined by the 4-2-1 rule. This is as follows:
- Maintenance fluid alone:
• 4 ml/kg for the first 10 kg of the patient’s weight
• 2 ml/kg for the second 10 kg of the patient’s weight
• 1 ml/kg for all the rest.
Practical Example on a 42 kg Patient undergoing surgery:
• 40 ml for the first 10kg (4 ml x 10 kg)
• 20 ml for the second 10kg (2 ml x 10 kg)
• 22 ml for the rest (1 ml x 22 kg)
• Total = 82 ml. This would be the hourly needs of the patient.
- NPO extra fluid calculation:
If the same patient had been NPO for 12 hours, he would need 984 ml of fluid to get
caught up (82 ml x 12 hours). This would typically be replaced over 3 hours. The first
hour would be half the volume, while the second and third hours would replace the
remaining volume in quarters. For example:
1st Hour 2nd Hour 3rd Hour
NPO 492 246 246
- Replacing Third Space Losses
• These surgical losses account for fluids that have moved out of the vascular
space. So, depending on the surgery, the losses here range far and wide. It ranges
between 0-10 ml/kg. So, let’s suppose it’s 4 ml/kg. This would mean that you
need to replace about 168 ml for every hour for the above patient (42 kg x 4 ml).
Let’s add it in:
1st Hour 2nd Hour 3rd Hour
NPO 492 246 246
Hourly 82 82 82
Surgical 168 168 168
Total 742 496 496
- Surgical blood losses can be difficult to estimate but is based on blood volume in
suction canisters, soaked gauzes and laparotomy pads. Surgical blood loss is
replaced in a 3 : 1 ratio of crystalloid to blood loss, and a 1 : 1 ratio if colloid is
administered.
TYPES OF VENOUS ACCESS
There are a variety of options available, and a venous access device must be selected based on
the duration of IV therapy, type of solution to be infused, and the needs of the patient. There
are two types of venous access: peripheral IV access and central venous catheters.
1- Peripheral IV is a common, preferred method for short-term IV therapy in the hospital
setting. A peripheral IV (PIV) is a short intravenous catheter inserted by percutaneous
venipuncture into a peripheral vein, held in place with a sterile transparent dressing to keep
the site sterile and prevent accidental dislodgement. Upper extremities (hands and arms) are
the preferred sites for insertion by a specially trained health care provider.
PIVs are used for infusions under six days and for solutions that are iso-osmotic. They are easy
to monitor and can be inserted at the bedside.
PIVs should be replaced every 72 to 96 hours to prevent infection and phlebitis in adults.
2- Central venous catheter (CVC), also known as a central line or central venous access
device, is an intravenous catheter that is inserted into a large vein in the central
circulation system, where the tip of the catheter terminates in the superior vena cava
(SVC) that leads to an area just above the right atrium. CVCs have become common in
health care settings for patients who require IV medication administration and other IV
treatment requirements. CVCs can remain in place for more than one year. Some CVC
devices may be inserted at the bedside, while other central lines are inserted surgically.
Ultrasound guided placement is recommended to reduce time of insertion and
complications.
A CVC has many advantages over a peripheral IV line, including the ability to deliver fluids
or medications that would be overly irritating to peripheral veins, and the ability to access
multiple lumens to deliver multiple medications at the same time. Central venous
catheters can be inserted percutaneously or surgically through the internal jugular,
subclavian, or via the chest or upper arm peripheral veins. Femoral veins are not
recommended, as the rate of infection is increased in adults. Site selection for a CVC may
be based on numerous factors, such as the condition of the patient, patient’s age, and
type and duration of IV therapy.
POTENTIAL LOCAL COMPLICATIONS OF PERIPHERAL IV THERAPY
Phlebitis is the inflammation of the vein’s inner lining, the tunica intima. Clinical indications are
localized redness, pain, heat, and swelling, which can track up the vein leading to a palpable
venous cord. Mechanical causes: Inflammation of the vein’s inner lining can be caused by the
cannula rubbing and irritating the vein. Chemical causes: Inflammation of the vein’s inner lining
can be caused by medications with a high alkaline, acidic, or hypertonic solutions.
Infiltration occurs when an IV solution is accidentally administered into surrounding tissue.
Signs and symptoms include pain, swelling, redness, skin surrounding insertion site is cool to
touch, change in quality or flow of IV, tight skin around IV site, IV fluid leaking from IV site, and
frequent alarms on the IV pump.
Extravasation is characterized by the same signs and symptoms as infiltration but also includes
burning, stinging, redness, blistering, or necrosis of the tissue.
Hemorrhage is defined as bleeding from the puncture site.
Local infection is indicated by purulent drainage from site, usually two to three days after an IV
site is started.
Theformulaforworkingoutflowratesis:
volume(ml) Xdrop factor (gtts /ml)
=gtts / min (flow rate)
Example:
1500mlIV.Salineisorderedover12hours.Usingadrop factor of 15drops/ ml,how manydropsper
minute needto bedelivered?
=31drops/minute
1500(ml) X15(drop /ml)
---------------------------------------------------------
12x 60 (givesustotalminutes)
---------------------------------------------
time (min)
How nurses calculate IV flow rates ?
Drop factor is the number of drops in one milliliter used in IV fluid administration
(also called drip factor).
Universal equations of IV flow rate and medication dosage calculation
With the advent of smart technology infusion pumps, unit dose preparations and standardized
concentrations by drug manufacturers and pharmacists; medication errors have been greatly reduced.
Even when the technology works well, and pharmacy support is optimal, nurses remain responsible for
safe administration of IV medications directly to patients. To fulfill this responsibility, nurses must
maintain competency in basic medication calculations.
How nurses calculate drug dosage?
Example:
• The ordered dose is Ceftriaxone 750 mg IV. the container contain 1g in a 10 ml vial.
• Youshould convert first g to mg , then :
(D) 750 mg X (V) 10 ml = 7.5 ml
(H) 1000 mg
D
H
x V=Amount to Give
D = dose ordered or desired dose
H = dose on container label or dose on hand
V = form and amount in which drug comes (tablet, capsule, liquid)
41
• Understanding the physiology of human fluid dynamics and the types of intravenous fluid
options available allows the clinician to optimize his/her treatment of surgical patients.
• The most important goal is to maintain hemodynamic stability and protect vital organs
(heart, liver, brain, and kidneys).
A twenty y/o euvolemic female patient, 50 kg,
admitted for Knee surgery.
•NPO after 0300, surgery at 0800.
•Estimated Fluid loss from surgical trauma 4ml/kg.
•3 hr. procedure, 200 cc blood loss.
•Crystalloid fluid will be administered.
Practical Quiz to calculate the estimated intraoperative fluid requirements
Answer
• 40 ml for the first 10kg (4 ml x 10 kg)
• 20 ml for the second 10kg (2 ml x 10 kg)
• 30 ml for the rest (1 ml x 30 kg)
• Total = 90 ml. This would be the hourly needs of the patient.
- NPO extra fluid calculation:
The same patient had been NPO for 5 hours, she would need 450 ml of fluid to get caught up
(90 ml x 5 hours). This would typically be replaced over 3 hours. The first hour would be half the volume,
while the second and third hours would replace the remaining volume in quarters.
1st Hour 2nd Hour 3rd Hour
NPO 225 112.5 112.5
• Surgical fluids lost out of the vascular space (50 kg x 4 ml)=200ml/hr.
1st Hour 2nd Hour 3rd Hour
• NPO 225 112.5 112.5
• Hourly 90 90 90
• Surgical 200 200 200
• Total 515 402.5 402.5
Surgical blood loss is replaced in a 3 : 1 ratio of crystalloid to blood loss= 200x3= 600ml.
Total estimated intraoperative fluid requirements= 515+402.5+402.5+600= 1,920 ml.

More Related Content

What's hot

Fluid And Electrolytes
Fluid And ElectrolytesFluid And Electrolytes
Fluid And Electrolytes
MD Specialclass
 
IV FLUID MANAGEMENT/ FLUID THERAPY
IV FLUID MANAGEMENT/ FLUID THERAPYIV FLUID MANAGEMENT/ FLUID THERAPY
IV FLUID MANAGEMENT/ FLUID THERAPY
Ashutosh Pakale
 
Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...
Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...
Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...
Ronald Magbitang
 
Coagulation abnormalities in critically ill patients 2
Coagulation abnormalities in critically ill patients 2Coagulation abnormalities in critically ill patients 2
Coagulation abnormalities in critically ill patients 2
tyfngnc
 
IV FLUIDS PART1
IV FLUIDS PART1IV FLUIDS PART1
IV FLUIDS PART1
Arundev P Nair
 
Fluids and electrolytes ppt
Fluids and electrolytes pptFluids and electrolytes ppt
Fluids and electrolytes ppt
rajat1906
 
CRRT for ICU nurses
CRRT for ICU nursesCRRT for ICU nurses
CRRT for ICU nurses
mansoor masjedi
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutrition
sania2014
 
Emergency Fluid Therapy
Emergency Fluid TherapyEmergency Fluid Therapy
Emergency Fluid TherapyRashidi Ahmad
 
Hypernatremia
HypernatremiaHypernatremia
Hypernatremia
shivarajapaed
 
Fluid management in icu dr vijay
Fluid management in icu dr vijayFluid management in icu dr vijay
Fluid management in icu dr vijay
Vijay Kumar
 
Postoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptxPostoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptx
AymanTaslima
 
Intravenous fluid therapy
Intravenous fluid therapyIntravenous fluid therapy
Intravenous fluid therapy
charul jakhwal
 
hypernatremia management
hypernatremia managementhypernatremia management
hypernatremia management
Pediatric Nephrology
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
Kanika Rustagi
 
Fluid and electrolyte management tata (2)
Fluid and electrolyte management tata (2)Fluid and electrolyte management tata (2)
Fluid and electrolyte management tata (2)
Tages H. Tata
 
Fluids and Electrolytes Therapy in Paediatric Surgery
Fluids and Electrolytes Therapy in Paediatric SurgeryFluids and Electrolytes Therapy in Paediatric Surgery
Fluids and Electrolytes Therapy in Paediatric Surgery
Arravindh Vivekananthan
 

What's hot (20)

Fluid And Electrolytes
Fluid And ElectrolytesFluid And Electrolytes
Fluid And Electrolytes
 
IV FLUID MANAGEMENT/ FLUID THERAPY
IV FLUID MANAGEMENT/ FLUID THERAPYIV FLUID MANAGEMENT/ FLUID THERAPY
IV FLUID MANAGEMENT/ FLUID THERAPY
 
Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...
Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...
Basic Intravenous Therapy 3: Fluids And Electrolytes, Balance and Imbalance, ...
 
Coagulation abnormalities in critically ill patients 2
Coagulation abnormalities in critically ill patients 2Coagulation abnormalities in critically ill patients 2
Coagulation abnormalities in critically ill patients 2
 
IV FLUIDS PART1
IV FLUIDS PART1IV FLUIDS PART1
IV FLUIDS PART1
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
Fluids and electrolytes ppt
Fluids and electrolytes pptFluids and electrolytes ppt
Fluids and electrolytes ppt
 
CRRT for ICU nurses
CRRT for ICU nursesCRRT for ICU nurses
CRRT for ICU nurses
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutrition
 
Emergency Fluid Therapy
Emergency Fluid TherapyEmergency Fluid Therapy
Emergency Fluid Therapy
 
Hypernatremia
HypernatremiaHypernatremia
Hypernatremia
 
Colloid vs Crystalloids
Colloid vs CrystalloidsColloid vs Crystalloids
Colloid vs Crystalloids
 
Fluid management in icu dr vijay
Fluid management in icu dr vijayFluid management in icu dr vijay
Fluid management in icu dr vijay
 
Postoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptxPostoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptx
 
Intravenous fluid therapy
Intravenous fluid therapyIntravenous fluid therapy
Intravenous fluid therapy
 
hypernatremia management
hypernatremia managementhypernatremia management
hypernatremia management
 
Fluid therapy2
Fluid therapy2Fluid therapy2
Fluid therapy2
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
Fluid and electrolyte management tata (2)
Fluid and electrolyte management tata (2)Fluid and electrolyte management tata (2)
Fluid and electrolyte management tata (2)
 
Fluids and Electrolytes Therapy in Paediatric Surgery
Fluids and Electrolytes Therapy in Paediatric SurgeryFluids and Electrolytes Therapy in Paediatric Surgery
Fluids and Electrolytes Therapy in Paediatric Surgery
 

Similar to Fluid balance for surgical patients. Dr. Ahmed khashaba, MD

6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,
6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,
6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,
linhnguyen37502
 
Fluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptxFluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptx
hrowshan
 
3-Fluid & elect-A (1).pptx
3-Fluid & elect-A (1).pptx3-Fluid & elect-A (1).pptx
3-Fluid & elect-A (1).pptx
jiregna5
 
fluid threopy in critically ill patients.pptx
fluid threopy in critically  ill  patients.pptxfluid threopy in critically  ill  patients.pptx
fluid threopy in critically ill patients.pptx
TiwariBalwan
 
Fluid and Electrolyte Imbalance.pptx
Fluid and Electrolyte Imbalance.pptxFluid and Electrolyte Imbalance.pptx
Fluid and Electrolyte Imbalance.pptx
MesfinShifara
 
Flud therapy in veterinary practices
Flud therapy in veterinary practicesFlud therapy in veterinary practices
Flud therapy in veterinary practices
MRafayBurhan
 
Fluids &amp; electrolytes seminar [autosaved]
Fluids &amp; electrolytes seminar [autosaved]Fluids &amp; electrolytes seminar [autosaved]
Fluids &amp; electrolytes seminar [autosaved]
Avinash Rathore
 
Iv therapy
Iv therapyIv therapy
Iv therapy
Kimber Leavitt
 
Intravenous fluids
Intravenous fluidsIntravenous fluids
Intravenous fluids
Siddharth Sood
 
Fluid management in Neurosurgery
Fluid management in NeurosurgeryFluid management in Neurosurgery
Fluid management in Neurosurgery
Dr. Tanmoy Roy
 
fluid imbalance and its management.pptx
fluid imbalance and its management.pptxfluid imbalance and its management.pptx
fluid imbalance and its management.pptx
Sapana Shrestha
 
Body fluids and electrolytes+Edema.pdf
Body fluids and electrolytes+Edema.pdfBody fluids and electrolytes+Edema.pdf
Body fluids and electrolytes+Edema.pdf
manjushashinde4
 
Fluids and electrolytes.pptx
Fluids and electrolytes.pptxFluids and electrolytes.pptx
Fluids and electrolytes.pptx
RUTAYISIRE François Xavier
 
fluid balance.pptx
fluid balance.pptxfluid balance.pptx
fluid balance.pptx
hagiralhaj
 
Iv fluids TYPES OF IV FLIUDS
Iv fluids  TYPES OF IV FLIUDSIv fluids  TYPES OF IV FLIUDS
Iv fluids TYPES OF IV FLIUDS
Mohamed Elbhnasawy
 
Iv Fluid Therapy by Faisal Azmi
Iv Fluid Therapy by Faisal AzmiIv Fluid Therapy by Faisal Azmi
Iv Fluid Therapy by Faisal Azmi
Faisal Azmi
 
Iv fluids
Iv fluidsIv fluids
Iv fluids
Dr Saqba Alam
 
Perioperative fluid management
Perioperative fluid managementPerioperative fluid management
Perioperative fluid managementShen-Chih Wang
 
Fluid Therapy.pptx
Fluid Therapy.pptxFluid Therapy.pptx
Fluid Therapy.pptx
DaryGunawan
 

Similar to Fluid balance for surgical patients. Dr. Ahmed khashaba, MD (20)

6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,
6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,
6614228 [Autosaved].pptx,,,,,,,,,,,,,,,,,,,,,,
 
Fluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptxFluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptx
 
3-Fluid & elect-A (1).pptx
3-Fluid & elect-A (1).pptx3-Fluid & elect-A (1).pptx
3-Fluid & elect-A (1).pptx
 
fluid threopy in critically ill patients.pptx
fluid threopy in critically  ill  patients.pptxfluid threopy in critically  ill  patients.pptx
fluid threopy in critically ill patients.pptx
 
Fluid and Electrolyte Imbalance.pptx
Fluid and Electrolyte Imbalance.pptxFluid and Electrolyte Imbalance.pptx
Fluid and Electrolyte Imbalance.pptx
 
Flud therapy in veterinary practices
Flud therapy in veterinary practicesFlud therapy in veterinary practices
Flud therapy in veterinary practices
 
Fluids &amp; electrolytes seminar [autosaved]
Fluids &amp; electrolytes seminar [autosaved]Fluids &amp; electrolytes seminar [autosaved]
Fluids &amp; electrolytes seminar [autosaved]
 
Iv therapy
Iv therapyIv therapy
Iv therapy
 
Fluid and electrolytes
Fluid and electrolytes Fluid and electrolytes
Fluid and electrolytes
 
Intravenous fluids
Intravenous fluidsIntravenous fluids
Intravenous fluids
 
Fluid management in Neurosurgery
Fluid management in NeurosurgeryFluid management in Neurosurgery
Fluid management in Neurosurgery
 
fluid imbalance and its management.pptx
fluid imbalance and its management.pptxfluid imbalance and its management.pptx
fluid imbalance and its management.pptx
 
Body fluids and electrolytes+Edema.pdf
Body fluids and electrolytes+Edema.pdfBody fluids and electrolytes+Edema.pdf
Body fluids and electrolytes+Edema.pdf
 
Fluids and electrolytes.pptx
Fluids and electrolytes.pptxFluids and electrolytes.pptx
Fluids and electrolytes.pptx
 
fluid balance.pptx
fluid balance.pptxfluid balance.pptx
fluid balance.pptx
 
Iv fluids TYPES OF IV FLIUDS
Iv fluids  TYPES OF IV FLIUDSIv fluids  TYPES OF IV FLIUDS
Iv fluids TYPES OF IV FLIUDS
 
Iv Fluid Therapy by Faisal Azmi
Iv Fluid Therapy by Faisal AzmiIv Fluid Therapy by Faisal Azmi
Iv Fluid Therapy by Faisal Azmi
 
Iv fluids
Iv fluidsIv fluids
Iv fluids
 
Perioperative fluid management
Perioperative fluid managementPerioperative fluid management
Perioperative fluid management
 
Fluid Therapy.pptx
Fluid Therapy.pptxFluid Therapy.pptx
Fluid Therapy.pptx
 

Recently uploaded

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 

Recently uploaded (20)

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 

Fluid balance for surgical patients. Dr. Ahmed khashaba, MD

  • 1. Fluid Balance For Surgical Patients 1 Dr. Ahmed Sayed Khashaba, MBBS. MD. Ph.D. Associate Professor of Medical Physiology College of Applied Medical Sciences Basic Sciences Department Riyadh Elm University Kingdom of Saudi Arabia, P.O. Box: 84891 Riyadh 11681 Tel: 0112481222, ext. 324 email: ahmedkhashaba@riyadh.edu.sa
  • 2. Intended Learning Outcomes • Describe the physiology of human fluid dynamics. • Define Intravenous therapy. • List the aims of adult perioperative fluid therapy. • Recognize the commonly used fluid preparations. • Describe the properties and indications of commonly used IV solutions. • Describe the side effects and precautions of commonly used IV solutions. • Explain the (NICE) principles and protocols for intravenous fluid therapy. • Discuss the assessment and management of hydration and volume status of surgical patients. • Describe the type, rate and volume of fluid administered to surgical patients. • Recognize the different types of venous access. • Explain the potential local complications of peripheral IV therapy. • Identify the universal equations used by nurses to calculate the IV flow rate and medication dosage.
  • 3. I. Physiology-Body Fluid Compartments ■Total body water (TBW) is approximately 60% of body weight. ■A. Distribution of water 1. Intracellular fluid (ICF) ■is two-thirds of TBW. ■The major cations of ICF are K+ and Mg2+. ■The major anions of ICF are protein and organic phosphates. 2. Extracellular fluid (ECF) ■is one-third of TBW. ■is composed of interstitial fluid and plasma. The major cation of ECF is Na+. ■The major anions of ECF are Cl- and HCO3-. a. Plasma is one-fourth of the ECF. ■The major plasma proteins are albumin and globulins. b. Interstitial fluid is three-fourths of the ECF. ■The composition of interstitial fluid is the same as that of Plasma except that it has little protein. Thus, interstitial fluid is an ultrafiltrate of plasma. 3. 60-40-20 rule ■TBW is 60% of body weight. ■ICF is 40% of body weight. ■ECF is 20% of body weight.
  • 4. 4- Normal Fluid Balance N.B. Water requirements increase by 100 to 150 mL/day for each ○C of body temperature elevation.
  • 5. 5. Examples of shifts of water between compartments a. Sweating in a desert—loss of water ■is also called hyperosmotic volume contraction. (1)The osmolarity of ECF increases because sweat is hyposmotic (relatively more water than salt is lost). (2)ECF volume decreases because of the loss of volume in the sweat. (3)Water shifts out of ICF; as a result of the shift, ICF osmolarity increases until it is equal to ECF osmolarity, and ICF volume decreases. b. Excessive NaCl intake—addition of NaCl ■is also called hyperosmotic volume expansion. (1)The osmolarity of ECF increases because osmoles (NaCl) have been added to the ECF. (2)Water shifts from ICF to ECF. As a result of this shift, ICF osmolarity increases until it equals that of ECF. (3)As a result of the shift of water out of the cells, ECF volume increases (volume expansion) and ICF volume decreases.
  • 6. II- Distribution of Electrolytes
  • 7. III. Concentration and dilution of urine
  • 8. • Produced by HYPOTHALAMUS. • Stored by POSTERIOR PITUITARY • Decrease amount of water loss • Vasoconstriction. • Made by cells of Adrenal cortex (Zona Glomerulosa) • Controls levels of Na+ & K+ in ECF. • Simultaneous reabsorption of Na+ & excretion of K+. • Water follows Na+ • Atrialnatriureticpeptide(ANP)made by cells of Right Atrium when blood volume increases (atria stretched). • Brain natriuretic peptide (BNP) produced from stretched ventricles. • Promote loss of water & Na+,(-) Renin, (-)ADH & Aldosterone 27 IV- Hormonal effects on fluid homeostasis
  • 9. V- Starling's forces • Represent the movement of fluids at the vascular endothelium. Starling's forces describe the movement of fluids at the vascular endothelium. Starling described 4 forces: (a) the capillary hydrostatic pressure, (b) the capillary oncotic pressure, (c) the interstitial hydrostatic pressure, and (d) the interstitial oncotic pressure. The sum of the four forces results in the net movement of small amounts of fluid across the vascular endothelium into the interstitial space. Normally, the lymphatic system returns this fluid to the circulation to prevent interstitial edema (Saraghi, M., 2015. Intraoperative fluids and fluid management for ambulatory dental sedation and general anesthesia). • In patients who are septic, the tight junctions between the capillary endothelial cells break down and vascular permeability increases. As a result, increasing hydrostatic pressures and reducing oncotic pressure lead to fluid leaving the vasculature and entering the tissue. It is often therefore necessary to give relatively large volumes of intravenous fluid to maintain the intra-vascular volume. Close monitoring of the fluid balance will be required.
  • 10. Definition: Intravenous therapy, also referred to as ‘IV therapy’, constitutes the administration of liquid substances directly into a vein and the general circulation through venepuncture (Mosby, 1998). INTRAVENOUS THERAPY
  • 11. 11 AIMS OF IV FLUID THERAPY The intravenous route is a fast and efficient method to administer fluids and medication, which can be given continuously or intermittently. Intravenous fluid therapy may be used to: • Replace fluids and replace imbalances. • Maintain fluid, electrolyte and acid-base balance. • Administer blood and blood products. • Administer medication. • Provide parenteral nutrition. • Monitor cardiac function.
  • 12. IV Fluids can be broadly categorized into two groups: 1- Crystalloids: are more widely used than colloids, with research supporting the idea that neither is superior in replenishing intravascular volume for resuscitation purposes (with crystalloids also significantly cheaper). Therefore, crystalloids are used very commonly in the acute setting, in theatres, and for maintenance fluids. 2- Colloids: One advantage of colloids is that they remain in the intravascular space for longer periods of time with less risk of peripheral and pulmonary edema. Commonly used colloids include albumin, hydroxyethyl starch, and dextran. Disadvantages include increased cost and risks for hypersensitivity reactions, coagulopathy, and renal failure. Colloids expand the volume of the intravascular space, resulting in dilution of blood cells, platelets, and coagulation can inhibit coagulation. Dextran, in particular, affect coagulation. Serious allergic or anaphylactoid reactions are another disadvantage associated with colloid administration. The crystalloid versus colloid debate continues and is one of the unresolved questions in perioperative fluid management.
  • 13. Compositions of Commonly Prescribed Crystalloids
  • 14. Properties and Indications of Commonly Used IV Fluids Different types of crystalloids have different properties and will, therefore, be appropriate in different situations according to the cause of fluid loss and the patient’s condition. 1- Isotonic crystalloids have a sodium and a chloride concentration of 154mmol/L and a similar electrolyte concentration to plasma. With isotonic infusions, there is no significant fluid shift across cellular or vascular membrane for a normally hydrated patient. These fluids are usually used to treat low extracellular fluid loss (for example, in a dehydrated patient), in fluid challenge or during fluid resuscitation. 2- Balanced crystalloid solutions (e.g., lactated Ringer’s). They are called ‘balanced’ because their ionic composition is closer to the human body’s plasma levels than other crystalloids. A post-operative patient at risk of fluid loss leading to electrolyte imbalance, for example, will benefit from balanced crystalloids. 3- Hypotonic crystalloids have a lower osmolarity than plasma, which means they cause fluids to shift from the intravascular space to the intracellular or interstitial space. They also help the kidneys excrete fluids and electrolytes, and are often used in patients with diabetic ketoacidosis. 4- Hypertonic crystalloids have a higher electrolyte concentration than plasma and, therefore, draw fluid from the intracellular and interstitial space into the intravascular space. They may be used to treat patients with cerebral oedema.
  • 15. IV FLUID CHOICE FOR DENTAL, ORAL, AND MAXILLOFACIAL PROCEDURES • For outpatient treatments involving sedation/general anesthesia and just modest blood loss, such as most dentistry and oral surgery, isotonic balanced crystalloids are the preferred fluid. • The majority of patients who come in for surgery have not just an intravascular fluid deficit but also an interstitial space deficit. Thankfully, crystalloid will compensate for the losses in both compartments. Insensible and urine losses are minimal in most office-based dental and oral surgery procedures. • Colloids have no place in office-based dental and minor oral treatments, and their use is limited to prolonged and/or invasive maxillofacial surgical operations involving significant blood loss and advanced monitoring of blood pressure and/or urinary output (Saraghi, M., 2015. Intraoperative fluids and fluid management for ambulatory dental sedation and general anesthesia).
  • 16. Side-effects and Precautions of Commonly Used IV Fluids 1- Isotonic crystalloids should be used with caution in patients with cardiac or renal disease, as there is a risk of fluid overload. Patients’ sodium and chloride levels need to be monitored regularly to avoid hypernatraemia and hyperchloraemia. All isotonic crystalloids can cause peripheral and pulmonary oedema. 2- The lactate contained in balanced isotonics is metabolized by the liver into bicarbonate, so these fluids should not be used in patients who cannot metabolize lactate due to liver disease; nor should they be administered to patients with pH >7.5. They should be used with caution in patients with renal failure because of the kidneys’ inability to filter potassium. 3- Hypotonic crystalloids should not be administered to patients at risk of increased intracranial pressure, those with liver disease or trauma or burns patients, mainly because these patients need to maintain a good intravascular volume. 4- Hypertonic crystalloids main risks are hypernatraemia and hyperchloraemia, so these fluids need to be given slowly and cautiously to avoid intravascular fluid overload and pulmonary oedema. It is also worth noting that 20% dextrose is an osmotic diuretic. Hypertonic solutions should not be given to patients with cardiac conditions, as there is a risk of fluid overload.
  • 17. IV Fluid Replacement Precautions in Specific Patients • Patients with hypernatremia who receive fluid replacement with quick correction of hypernatremia are more likely to develop cerebral edema due to increased intracellular and extracellular fluid loads, as well as increased pressure inside the brain region. This results in neurological damage and, eventually, death. This situation can be averted by slowly infusing fluids to lower sodium levels at a rate of 2 to 3 mEq/L per hour for a total change of 12 mEq/L per day until sodium levels return to normal. • Rapid correction of hyponatremic patients, on the other hand, may result in central pontine myelinolysis syndrome. When hyponatremia is quickly treated, brain cells shrink and the blood-brain barrier's tight connections are broken, resulting in cell injury and neuron demyelination. This can result in a condition known as "locked-in syndrome’’ which is characterized by paralysis, dysphagia, and dysarthria. The serum sodium should be increased by approximately 1 to 2 mEq/L per hour until the neurologic symptoms of hyponatremia subside or until plasma sodium concentration is over 120 mEq/L. • Diabetic ketoacidosis is a diabetic condition that occurs when the body is unable to use glucose for energy production. Glucose is an osmotically active molecule excreted at high amounts in the urine (osmotic diuresis). Dehydration arises as a result of the excessive fluid loss through urine. This demands a large volume resuscitation of approximately 6 to 9 liters of normal saline (Brinkman, J.E., Dorius, B. and Sharma, S., 2018. Physiology, Body Fluids).
  • 18. National Institute for Health and Care Excellence (NICE) Principles and protocols for intravenous fluid therapy • The assessment and management of patients’ fluid and electrolyte needs are fundamental to good patient care. Fluid balance is an important area of perioperative medicine. If managed incorrectly it is a significant cause of morbidity. • Provide intravenous (IV) fluid therapy only for patients whose needs cannot be met by oral or enteral routes, and stop as soon as possible. • When prescribing IV fluids, remember the five Rs after the initial assessment: resuscitation, routine maintenance, replacement, redistribution, and reassessment. •  Offer IV fluid therapy as part of the following protocol: – Assess patients’ fluid and electrolyte needs following algorithm 1 (assessment) – If patients need IV fluids for resuscitation, follow algorithm 2 (fluid resuscitation) – If patients need IV fluids for routine maintenance, follow algorithm 3 (routine maintenance) – If patients need IV fluids to address existing deficits or excesses, ongoing abnormal losses, or abnormal fluid distribution, follow algorithm 4 (replacement and redistribution). • Include the following information in IV fluid prescriptions: – The type of fluid to be administered – The rate and volume of fluid to be administered. – The fluid and electrolyte prescription over the next 24 hours.
  • 19.
  • 20. I- Assessment of Fluid Status • It is essential to utilize various clinical parameters to continually assess the patient’s fluid status. A doctor’s first assessment is the patient’s clinical status. • Assess the patient using the ABCDE approach (airway, breathing, circulation, disability, exposure). A- In the fluid depleted patients (HYPOVOLEMIA), one should be looking for: • Dry mucous membranes and reduced skin turgor • Decreasing urine output (should target >0.5 ml/kg/hr) • Orthostatic hypotension • In worsening stages: • Systolic blood pressure <100mmHg; • Heart rate >90 beats per minute; • Capillary refill time >2 seconds or peripheries cold to touch; • Respiratory rate >20 breaths per minute; • NEWS ≥ 5. • Passive leg raising suggesting fluid responsiveness. B- In patients who may be fluid overloaded (HYPERVOLEMIA), one should be looking for: • Raised Jugular Venous Pressure (JVP) • Peripheral or sacral oedema • Pulmonary oedema C- Ensure that the patient has a fluid input-output chart and daily weight chart commenced via nursing staff. Also ensure to monitor the patient’s urea and electrolytes (U&Es) regularly, for any evidence of dehydration, renal hypoperfusion, or electrolyte abnormalities.
  • 21. N.B. NEWS should be used as an aid to clinical assessment, and is not a substitute for sound clinical judgement. Therefore a low score is not necessarily reassuring but the higher the NEWS, the greater the clinical risk. A *RED score refers to an extreme variation in a single physiological parameter and warrants clinical evaluation.
  • 22. N.B. Hypervolemia can be managed by fluid restriction, diuretics, and dialysis in severe cases.
  • 23. II. RESUSCITATION Resuscitation is correction of existing abnormalities in volume status or serum electrolytes (as in hypovolemic shock). • Regardless of the etiology of volume depletion, the mainstay of treatment strategy is a goal-directed resuscitation to restore intravascular volume. This will contribute to improved cardiovascular function and tissue perfusion. • As the extracellular space is restored, focus can begin to shift towards maintaining the current extracellular volume state and restoring intracellular volume. Electrolyte correction can occur during and after the maintenance phase is established. • Correction may be anticipated from the clinical context and verified using diagnostic tests. • With adequate tissue perfusion, most pH abnormalities should correct. • The inverted pyramid below illustrates the focus of acute management in descending order of priority:
  • 24. II- RESUSCITATION (Continued) • Any reduced urine output (<0.5ml/kg/hr.) should be managed aggressively, the fluid challenge should be urgently administered according to the clinical parameters, including the urine output. • The fluid challenge should be either 250ml or 500ml over 15-30mins, depending on the patient’s size and co-morbidities. • Fluids can be given in a variety of ways. A large observational research revealed significant differences in practice. Crystalloids made up 74.3 percent of the fluids utilized in the challenge, with 0.9 percent saline accounting for 45.9 percent and 53.5 percent balanced solutions, with colloids accounting for the remaining 25.6 percent (Cecconi, Maurizio, et al. 2015. Fluid challenges in intensive care: the FENICE study). • Ongoing Monitoring of Fluid Challenge Frank Starlings Law and SV maximization: • The relationship between preload and stroke volume is best described by the Frank-Starling curve. An increased venous return, or increased preload increases ventricular filling and the end-diastolic volume. This increases the stretch of the cardiac myocyte, which increases sarcomere length with the resultant increased force of contraction, leading to an increase in the volume of blood ejected from the heart. For a fluid challenge to be effective, it, therefore, needs to be of sufficient volume to cause stretch of the cardiac myocytes and test the Frank- Starling principle. If the heart can accommodate the increased volume, then stroke volume will increase; otherwise, the volume will remain within the venous system (Bennett, V.A. and Cecconi, M., 2017. Perioperative fluid management: From physiology to improving clinical outcomes).
  • 25. Frank Starlings Law and SV maximization N.B. When giving the fluid challenge, the following are the signs of fluid responsiveness: • ≥ 10–15% increase in cardiac output (CO) or stroke volume (SV) • Increase in systolic blood pressure • Normalization of heart rate and respiratory rate • Increase in urine output ≥ 0.5 mL/kg/hour
  • 26. A number of minimally invasive and noninvasive diagnostic tools are currently available that allow clinicians to assess volume responsiveness using dynamic procedures that challenge the patients' Frank-Starling curve. These technologies complement one another; each has a useful place in the continuum of the resuscitation process. N.B. Esophageal Doppler monitoring (EDM) was recently endorsed by the National Health Service as a rational alternative to central venous pressure monitoring in patients undergoing major surgery.
  • 27. III- Routine Maintenance (Daily Requirements) • Providing the patient’s renal function is adequate and is Clinically Euvolemic, maintenance therapy is usually undertaken when the individual is not expected to eat or drink normally for a longer time (e.g., perioperatively or patient on a ventilator). • Patients do not just require water, they also need Na+, K+, and glucose replacing too, particularly if they are nil by mouth (NPO). There are numerous ways of calculating the daily requirements of the following four components and they are invariably based on the patient’s weight. • Current National Institute for Health and Care Excellence (NICE) guidelines suggest the following: • 1- Water: 25 mL/kg/day • 2- Na+: 1.0 mmol/kg/day • 3- K+: 1.0 mmol/kg/day • 4- Glucose: 50g/day Based on these required, it is necessary to consider the fluids that are available for prescription and what exactly they contain, to be able to prescribe appropriately.
  • 28. A Practical Example on Routine Maintenance: - Let us say that our patient is a 70kg healthy male. • From the daily requirements mentioned in the previous slide, we need to prescribe fluids over 24 hours that provide 1750mL of water (70kg x 25mL/kg/day), 70mmol of Na+ (70kg x 1.0mmol/kg/day), 70mmol of K+ (70kg x 1.0mmol/kg/day), and 50g (50g/day) of glucose. • Consequently, a typical fluid maintenance regimen is as follows: • First bag: 500mL of 0.9% saline with 20mmol/L K+ to be run over 8 hours • This provides all of their Na+, ~1/3rd of their K+, and a quarter of their water. • Second bag: 1L of 5% dextrose with 20mmol/L K+ to run over 8 hours • This provides a further 1/3rd of their K+, and half of their water, as well as glucose. • Third bag: 500mL of 5% dextrose with 20mmol/L K+ to run over 8 hours • This provides the remaining 1/3rd of their K+, and a quarter of their water, as well as glucose.
  • 29. IV- Replacement and Redistribution Aspects to be replaced may include: • Are there any third-space losses? • Third-space losses refer to fluid losses into spaces that are not visible, such as the bowel lumen (in bowel obstruction) or the retroperitoneum (as in pancreatitis). • Is the patient losing electrolyte-rich fluid? Common scenarios of electrolyte imbalances through fluid losses that may be encountered include dehydration (high urea: creatinine ratio and high PCV), vomiting (low K+, low Cl–, and alkalosis), or diarrhea (low K+ and acidosis).
  • 30. A. Dehydration Dehydration is largely due to inadequate water intake to meet the body’s metabolic needs. The average adult has an obligatory intake requirement of 1500 mL per day. This value increases depending on activity and metabolism. Primary sources of normal fluid loss include urine, sweat, respiration, and stool. • Dehydration manifests clinically as decreased urine output, dizziness, fatigue, tachycardia, increased skin turgidity, and fatigue or confusion in severe cases. • Whenever possible, oral fluid replacement should be attempted. In more urgent situations, IV fluid replenishment should be based on bolus supplementation of the deficit of fluids and a maintenance replenishment of obligatory intake requirements. The fluid deficit can be calculated when the pre-dehydration weight and post-dehydration weight are known. • The equation in males is: Deficit = 0.6 X weight in kilograms X [1-(140/measured Na+)] • The equation in females is: Deficit = 0.5 X weight in kilograms X [1-(140/measured Na+)] • IV fluid replacement options include normal saline (0.9% NaCl), one-half normal saline (0.45% NaCl), Dextrose 5% in either normal saline or one-half normal saline, and lactated Ringer's solution. • The choice of replacement fluids is patient scenario-specific and dependent on the electrolyte status of laboratory evaluation.
  • 31. B. Vomiting A man is admitted to the hospital for evaluation of severe epigastric pain. He has had persistent nausea and vomiting for 4 days. Upper gastrointestinal (GI) endoscopy shows a pyloric ulcer with partial gastric outlet obstruction. He has orthostatic hypotension, decreased serum [K+], decreased serum [Cl−], arterial blood gases consistent with metabolic alkalosis, and decreased ventilation rate. a. Loss of H+ from the stomach by vomiting causes increased blood [HCO3-] and metabolic alkalosis. Because Cl− is lost from the stomach along with H+, hypochloremia and ECF volume contraction occur. b. The decreased ventilation rate is the respiratory compensation for metabolic alkalosis. c. ECF volume contraction is associated with production of angiotensin II is increased. Thus, the ECF volume contraction worsens the metabolic alkalosis because angiotensin II increases HCO3− reabsorption in the proximal tubule (contraction alkalosis). d. The increased levels of aldosterone causes increased distal H+ secretion, further worsening the metabolic alkalosis. e. The choice of the IV fluid replacement fluid is dependent on the electrolyte status of laboratory evaluation to correct ECF volume contraction.
  • 32. C. Diarrhea A man returns from a trip abroad with “traveler’s diarrhea.” He has weakness, weight loss, orthostatic hypotension, increased pulse rate, increased breathing rate, pale skin, a serum [Na+] of 132 mEq/L, a serum [Cl−] of 111 mEq/L, and a serum [K+] of 2.3 mEq/L. His arterial blood gases are pH, 7.25; Pco2, 24 mm Hg; HCO3-, 10.2 mEq/L. a. Loss of HCO3- from the GI tract causes a decrease in the blood [HCO3−] and, according to the Henderson-Hasselbalch equation, a decrease in blood pH. Thus, this man has metabolic acidosis. b. The increased breathing rate (hyperventilation) is the respiratory compensation for metabolic acidosis. c. As a result of his diarrhea, this man has ECF volume contraction, which leads to decreases in blood volume and arterial pressure. The decrease in arterial pressure activates the baroreceptor reflex, resulting in increased sympathetic outflow to the heart and blood vessels. The increased pulse rate is a consequence of increased sympathetic activity in the sinoatrial (SA) node, and the pale skin is the result of cutaneous vasoconstriction. d. ECF volume contraction also activates the renin–angiotensin–aldosterone system. Increased levels of aldosterone lead to increased distal K+ secretion and hypokalemia. Loss of K+ in diarrhea fluid also contributes to hypokalemia. e. Treatment consists of replacing all fluid and electrolytes lost in diarrhea fluid and urine, including Na+, HCO3−, and K+ by administrating isotonic balanced IV fluid. e- If more Potassium IV infusion is indicated, it should not be administered exceeding 10 mmol/hour, and maximum dose in 24 hours should not exceed 200 mmol.
  • 33. V. Reassessment • If the patient is receiving IV fluids for resuscitation, reassess the patient using the ABCDE; monitor respiratory rate, pulse, blood pressure, and perfusion continuously; and measure venous lactate level or arterial pH and base excess according to the Resuscitation Council’s guidance on advanced life support. • All patients continuing to receive IV fluids need regular monitoring. This should initially include at least daily reassessments of clinical fluid status, laboratory values (urea, creatinine, and electrolytes), and fluid balance charts, along with weight measurement twice weekly. • Additional monitoring of urinary sodium may be helpful in patients with high volume gastrointestinal losses: reduced urinary sodium excretion (<30 mmol/L) may indicate total body sodium depletion even if plasma sodium levels are normal; however, urinary sodium values may be misleading in the presence of renal impairment or diuretic therapy. • If patients have received IV fluids containing chloride concentrations >120 mmol/L (such as saline 0.9%), monitor their serum chloride concentration daily. If patients develop hyperchloraemic acidosis, reassess their IV fluid prescription and assess their acid-base status. Using balanced electrolyte solutions that contain base or base-equivalents and chloride concentrations that are more physiologic may not only prevent the development of hyperchloremic acidosis, but may avoid some of the possible harmful effects of associated with hyperchloremic solutions such as normal saline.
  • 34. Hourly maintenance is determined by the 4-2-1 rule. This is as follows: - Maintenance fluid alone: • 4 ml/kg for the first 10 kg of the patient’s weight • 2 ml/kg for the second 10 kg of the patient’s weight • 1 ml/kg for all the rest. Practical Example on a 42 kg Patient undergoing surgery: • 40 ml for the first 10kg (4 ml x 10 kg) • 20 ml for the second 10kg (2 ml x 10 kg) • 22 ml for the rest (1 ml x 22 kg) • Total = 82 ml. This would be the hourly needs of the patient. - NPO extra fluid calculation: If the same patient had been NPO for 12 hours, he would need 984 ml of fluid to get caught up (82 ml x 12 hours). This would typically be replaced over 3 hours. The first hour would be half the volume, while the second and third hours would replace the remaining volume in quarters. For example: 1st Hour 2nd Hour 3rd Hour NPO 492 246 246
  • 35. - Replacing Third Space Losses • These surgical losses account for fluids that have moved out of the vascular space. So, depending on the surgery, the losses here range far and wide. It ranges between 0-10 ml/kg. So, let’s suppose it’s 4 ml/kg. This would mean that you need to replace about 168 ml for every hour for the above patient (42 kg x 4 ml). Let’s add it in: 1st Hour 2nd Hour 3rd Hour NPO 492 246 246 Hourly 82 82 82 Surgical 168 168 168 Total 742 496 496 - Surgical blood losses can be difficult to estimate but is based on blood volume in suction canisters, soaked gauzes and laparotomy pads. Surgical blood loss is replaced in a 3 : 1 ratio of crystalloid to blood loss, and a 1 : 1 ratio if colloid is administered.
  • 36. TYPES OF VENOUS ACCESS There are a variety of options available, and a venous access device must be selected based on the duration of IV therapy, type of solution to be infused, and the needs of the patient. There are two types of venous access: peripheral IV access and central venous catheters. 1- Peripheral IV is a common, preferred method for short-term IV therapy in the hospital setting. A peripheral IV (PIV) is a short intravenous catheter inserted by percutaneous venipuncture into a peripheral vein, held in place with a sterile transparent dressing to keep the site sterile and prevent accidental dislodgement. Upper extremities (hands and arms) are the preferred sites for insertion by a specially trained health care provider. PIVs are used for infusions under six days and for solutions that are iso-osmotic. They are easy to monitor and can be inserted at the bedside. PIVs should be replaced every 72 to 96 hours to prevent infection and phlebitis in adults.
  • 37. 2- Central venous catheter (CVC), also known as a central line or central venous access device, is an intravenous catheter that is inserted into a large vein in the central circulation system, where the tip of the catheter terminates in the superior vena cava (SVC) that leads to an area just above the right atrium. CVCs have become common in health care settings for patients who require IV medication administration and other IV treatment requirements. CVCs can remain in place for more than one year. Some CVC devices may be inserted at the bedside, while other central lines are inserted surgically. Ultrasound guided placement is recommended to reduce time of insertion and complications. A CVC has many advantages over a peripheral IV line, including the ability to deliver fluids or medications that would be overly irritating to peripheral veins, and the ability to access multiple lumens to deliver multiple medications at the same time. Central venous catheters can be inserted percutaneously or surgically through the internal jugular, subclavian, or via the chest or upper arm peripheral veins. Femoral veins are not recommended, as the rate of infection is increased in adults. Site selection for a CVC may be based on numerous factors, such as the condition of the patient, patient’s age, and type and duration of IV therapy.
  • 38. POTENTIAL LOCAL COMPLICATIONS OF PERIPHERAL IV THERAPY Phlebitis is the inflammation of the vein’s inner lining, the tunica intima. Clinical indications are localized redness, pain, heat, and swelling, which can track up the vein leading to a palpable venous cord. Mechanical causes: Inflammation of the vein’s inner lining can be caused by the cannula rubbing and irritating the vein. Chemical causes: Inflammation of the vein’s inner lining can be caused by medications with a high alkaline, acidic, or hypertonic solutions. Infiltration occurs when an IV solution is accidentally administered into surrounding tissue. Signs and symptoms include pain, swelling, redness, skin surrounding insertion site is cool to touch, change in quality or flow of IV, tight skin around IV site, IV fluid leaking from IV site, and frequent alarms on the IV pump. Extravasation is characterized by the same signs and symptoms as infiltration but also includes burning, stinging, redness, blistering, or necrosis of the tissue. Hemorrhage is defined as bleeding from the puncture site. Local infection is indicated by purulent drainage from site, usually two to three days after an IV site is started.
  • 39. Theformulaforworkingoutflowratesis: volume(ml) Xdrop factor (gtts /ml) =gtts / min (flow rate) Example: 1500mlIV.Salineisorderedover12hours.Usingadrop factor of 15drops/ ml,how manydropsper minute needto bedelivered? =31drops/minute 1500(ml) X15(drop /ml) --------------------------------------------------------- 12x 60 (givesustotalminutes) --------------------------------------------- time (min) How nurses calculate IV flow rates ? Drop factor is the number of drops in one milliliter used in IV fluid administration (also called drip factor). Universal equations of IV flow rate and medication dosage calculation With the advent of smart technology infusion pumps, unit dose preparations and standardized concentrations by drug manufacturers and pharmacists; medication errors have been greatly reduced. Even when the technology works well, and pharmacy support is optimal, nurses remain responsible for safe administration of IV medications directly to patients. To fulfill this responsibility, nurses must maintain competency in basic medication calculations.
  • 40. How nurses calculate drug dosage? Example: • The ordered dose is Ceftriaxone 750 mg IV. the container contain 1g in a 10 ml vial. • Youshould convert first g to mg , then : (D) 750 mg X (V) 10 ml = 7.5 ml (H) 1000 mg D H x V=Amount to Give D = dose ordered or desired dose H = dose on container label or dose on hand V = form and amount in which drug comes (tablet, capsule, liquid)
  • 41. 41 • Understanding the physiology of human fluid dynamics and the types of intravenous fluid options available allows the clinician to optimize his/her treatment of surgical patients. • The most important goal is to maintain hemodynamic stability and protect vital organs (heart, liver, brain, and kidneys).
  • 42. A twenty y/o euvolemic female patient, 50 kg, admitted for Knee surgery. •NPO after 0300, surgery at 0800. •Estimated Fluid loss from surgical trauma 4ml/kg. •3 hr. procedure, 200 cc blood loss. •Crystalloid fluid will be administered. Practical Quiz to calculate the estimated intraoperative fluid requirements
  • 43. Answer • 40 ml for the first 10kg (4 ml x 10 kg) • 20 ml for the second 10kg (2 ml x 10 kg) • 30 ml for the rest (1 ml x 30 kg) • Total = 90 ml. This would be the hourly needs of the patient. - NPO extra fluid calculation: The same patient had been NPO for 5 hours, she would need 450 ml of fluid to get caught up (90 ml x 5 hours). This would typically be replaced over 3 hours. The first hour would be half the volume, while the second and third hours would replace the remaining volume in quarters. 1st Hour 2nd Hour 3rd Hour NPO 225 112.5 112.5 • Surgical fluids lost out of the vascular space (50 kg x 4 ml)=200ml/hr. 1st Hour 2nd Hour 3rd Hour • NPO 225 112.5 112.5 • Hourly 90 90 90 • Surgical 200 200 200 • Total 515 402.5 402.5 Surgical blood loss is replaced in a 3 : 1 ratio of crystalloid to blood loss= 200x3= 600ml. Total estimated intraoperative fluid requirements= 515+402.5+402.5+600= 1,920 ml.